Targeted radionuclide therapy in combined-modality regimens-Reference-Cited by-同舟云学术

Targeted radionuclide therapy in combined-modality regimens

Published:2017-07 Issue:7 Volume:18 Page:e414-e423
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Gill Martin R,Falzone Nadia,Du Yong,Vallis Katherine A

Publisher

Elsevier BV

Subject

Oncology

Reference90 articles.

1. Decade in review-targeted therapy: successes, toxicities and challenges in solid tumours;Neal;Nat Rev Clin Oncol,2014

2. Combine and conquer: challenges for targeted therapy combinations in early phase trials;Lopez;Nat Rev Clin Oncol,2017

3. Clinical radioimmunotherapy: the role of radiobiology;Pouget;Nat Rev Clin Oncol,2011

4. Adjuvant intraarterial lipiodol or 131I-lipiodol after curative treatment of hepatocellular carcinoma: a prospective randomized trial;Dumortier;J Nucl Med,2014

5. Influence of tumour size on the efficacy of targeted alpha therapy with (213)Bi-[DOTA(0),Tyr(3)]-octreotate;Chan;Eur J Nucl Med Mol Imaging Res,2016

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy;Nuclear Medicine and Biology;2024-09

2. Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review;Frontiers in Oncology;2024-08-22

3. Targeted Radionuclide Therapy in Glioblastoma;ACS Applied Materials & Interfaces;2024-07-23

4. Voxel-Level Dosimetry for Combined Iodine 131 Radiopharmaceutical Therapy and External Beam Radiation Therapy Treatment Paradigms for Head and Neck Cancer;International Journal of Radiation Oncology*Biology*Physics;2024-07

5. Enhanced radiotheranostic targeting of integrin α5β1 with PEGylation-enabled peptide multidisplay platform (PEGibody): A strategy for prolonged tumor retention with fast blood clearance;Acta Pharmaceutica Sinica B;2024-07